SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001415889-18-001188
Filing Date
2018-07-26
Accepted
2018-07-26 18:22:53
Documents
1
Period of Report
2018-01-11

Document Format Files

Seq Description Document Type Size
1 form4a-07262018_030737.html 4/A  
1 form4a-07262018_030737.xml 4/A 14387
  Complete submission text file 0001415889-18-001188.txt   15825
Mailing Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317
Business Address
BORKOWSKI EDWARD (Reporting) CIK: 0001197542 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37853 | Film No.: 18972771

Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Issuer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1